Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CARsgen Therapeutics

CARsgen Therapeutics
2014 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series C LATEST DEAL TYPE
$60M LATEST DEAL AMOUNT
7 INVESTORS
Description

Developer of CAR-T cell therapy designed to focus on treating solid tumor. The company's CAR-T cell therapy uses antigen receptor T-cell (CAR-T) therapeutics to fight against tumor with a perspective to cure cancer, enabling physicians to deliver safe, effective and accessible treatments for patients.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Primary Office
  • 1F, Building 2, Number 466 Yindu Road
  • Xuhui District
  • Shanghai, 200231
  • China

+86 021 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CARsgen Therapeutics’s full profile, request a free trial.

CARsgen Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 02-Mar-2018 $60M 000.00 Completed Clinical Trials - Phase 1
3. Accelerator/Incubator 05-Dec-2019 000.00 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series B) 25-Jan-2016 $30M $31.6M Completed Startup
1. Early Stage VC (Series A) 26-Nov-2014 $1.63M $1.63M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

CARsgen Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator Minority 000 0000 000000 0
Photon Fund Venture Capital Minority 000 0000 000000 0
JIC GenesisFountain Healthcare Ventures Venture Capital Minority 000 0000 000000 0
Jolly Innovation Ventures Venture Capital Minority 000 0000 000000 0
Kaitai Capital Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

CARsgen Therapeutics Executive Team (7)

Name Title Board
Seat
Contact
Info
Zonghai Li MD Co-Founder, Chairman, Chief Executive Officer and Chief Scientific Officer
Huamao Wang Ph.D Chief Operating Officer & Co-Founder
Haiou Chen Executive Vice President, Financial & HR
Leigh Hsu Ph.D Senior Vice President, Business Development
Jie Jia Ph.D Vice President, Strategic Alliances and Operations

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

CARsgen Therapeutics Board Members (2)

Name Representing Role Since Contact
Info
Chi Hyun KTB Ventures Board Member 000 0000
Zonghai Li MD CARsgen Therapeutics Co-Founder, Chairman, Chief Executive Officer and Chief Scientific Officer 000 0000